HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina

Gene

Volumn 518, Issue 2, 2013, Pages 267-272

  Ekici, Arif B ^a   Strissel, Pamela L ^a   Oppelt, Patricia G ^a   Renner, Stefan P ^a   Brucker, Sara ^b   Beckmann, Matthias W ^a   Strick, Reiner ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Homeodomain; MRKH syndrome; Sequence variation; Uterine aplasia

Indexed keywords

CYTOSINE; HOXA13 PROTEIN; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR HOXA10; UNCLASSIFIED DRUG;

ADULT; AGENESIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FEMALE GENITAL TRACT MALFORMATION; GENE DELETION; HUMAN; KIDNEY MALFORMATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; ROKITANSKY SYNDROME; STOP CODON; UNTRANSLATED REGION;

ABNORMALITIES, MULTIPLE; AMINO ACID SUBSTITUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HOMEODOMAIN PROTEINS; HUMANS; KIDNEY; MULLERIAN DUCTS; MUTATION, MISSENSE; SOMITES; SPINE; UTERUS; VAGINA;

EID: 84875375665     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.01.030     Document Type: Article

References (48)

1. Bendavid C., et al. Phenotypic variability of a 4q34→qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother. Eur. J. Med. Genet. 2007, 50:66-72.
2. Ben-Rafael Z., Bar-Hava I., Levy T., Orvieto R. Simplifying ovulation induction for surrogacy in women with Mayer-Rokitansky-Kuster-Hauser syndrome. Hum. Reprod. 1998, 13:1470-1471.
3. Benson G.V., Lim H., Paria B.C., Satokata I., Dey S.K., Maas R.L. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 1996, 122:2687-2696.
4. Bernardini L., et al. Recurrent microdeletion at 17q12 as a cause of Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: two case reports. Orphanet J. Rare Dis. 2009, 4:25.
5. Biason-Lauber A., Konrad D., Navratil F., Schoenle E.J. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46, XX woman. N. Engl. J. Med. 2004, 351:792-798.
6. Biason-Lauber A., De Filippo G., Konrad D., Scarano G., Nazzaro A., Schoenle E.J. WNT4 deficiency-a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum. Reprod. 2007, 22:224-229.
7. Block K., Kardana A., Igarashi P., Taylor H.S. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB J. 2000, 14:1101-1108.
8. Burel A., et al. Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina). J. Negat. Results Biomed. 2006, 5:4.
9. Buttram V.C., Gibbons W.E. Mullerian anomalies: a proposed classification. (An analysis of 144 cases). Fertil. Steril. 1979, 32:40-46.
10. Cheng Z., et al. A novel mutation of HOXA10 in a Chinese woman with a Mullerian duct anomaly. Hum. Reprod. 2011, 26:3197-3201.
11. Cheroki C., et al. Report of a del22q11 in a patient with Mayer-Rokitansky-Kuster-Hauser (MRKH) anomaly and exclusion of WNT-4, RAR-gamma, and RXR-alpha as major genes determining MRKH anomaly in a study of 25 affected women. Am. J. Med. Genet. A 2006, 140:1339-1342.
12. Cheroki C., et al. Genomic imbalances associated with Mullerian aplasia. J. Med. Genet. 2008, 45:228-232.
13. Clement-Ziza M., et al. Exclusion of WNT4 as a major gene in Rokitansky-Kuster-Hauser anomaly. Am. J. Med. Genet. A 2005, 137:98-99.
14. Devriendt K., Moerman P., Van Schoubroeck D., Vandenberghe K., Fryns J.P. Chromosome 22q11 deletion presenting as the Potter sequence. J. Med. Genet. 1997, 34:423-425.
15. Du H., Taylor H.S. Molecular regulation of Mullerian development by Hox genes. Ann. N. Y. Acad. Sci. 2004, 1034:152-165.
16. Duncan P.A., Shapiro L.R., Stangel J.J., Klein R.M., Addonizio J.C. The MURCS association: Mullerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasia. J. Pediatr. 1979, 95:399-402.
17. Ergun A., Pabuccu R., Atay V., Kucuk T., Duru N.K., Gungor S. Three sisters with septate uteri: another reference to bidirectional theory. Hum. Reprod. 1997, 12:140-142.
18. Gendron R.L., Paradis H., Hsieh-Li H.M., Lee D.W., Potter S.S., Markoff E. Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol. Reprod. 1997, 56:1097-1105.
19. Goodman F.R., et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am. J. Hum. Genet. 2000, 67:197-202.
20. Hombria J.C., Lovegrove B. Beyond homeosis-HOX function in morphogenesis and organogenesis. Differentiation 2003, 71:461-476.
21. Innis J.W., et al. A HOXA13 allele with a missense mutation in the homeobox and a dinucleotide deletion in the promoter underlies Guttmacher syndrome. Hum. Mutat. 2002, 19:573-574.
22. Jones H.W., Mermut S. Familial occurrence of congenital absence of the vagina. Am. J. Obstet. Gynecol. 1972, 114:1100-1101.
23. Klopocki E., et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am. J. Hum. Genet. 2007, 80:232-240.
24. Lalwani S., Wu H.H., Reindollar R.H., Gray M.R. HOXA10 mutations in congenital absence of uterus and vagina. Fertil. Steril. 2008, 89:325-330.
25. Ledig S., Schippert C., Strick R., Beckmann M.W., Oppelt P.G., Wieacker P. Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil. Steril. 2011, 95:1589-1594.
26. Liatsikos S.A., et al. HOX A10 and HOX A11 mutation scan in congenital malformations of the female genital tract. Reprod. Biomed. Online 2010, 21:126-132.
27. Morcel K., et al. Utero-vaginal aplasia (Mayer-Rokitansky-Kuster-Hauser syndrome) associated with deletions in known DiGeorge or DiGeorge-like loci. Orphanet J. Rare Dis. 2011, 6:9.
28. Morcel K., Dallapiccola B., Pasquier L., Watrin T., Bernardini L., Guerrier D. Clinical utility gene card for: Mayer-Rokitansky-Kuster-Hauser syndrome. Eur. J. Hum. Genet. 2012, 20.
29. Mortlock D.P., Innis J.W. Mutation of HOXA13 in hand-foot-genital syndrome. Nat. Genet. 1997, 15:179-180.
30. Nahum G.G. Uterine anomalies. How common are they, and what is their distribution among subtypes?. J. Reprod. Med. 1998, 43:877-887.
31. Nik-Zainal S., et al. High incidence of recurrent copy number variants in patients with isolated and syndromic Mullerian aplasia. J. Med. Genet. 2011, 48:197-204.
32. Oppelt P., et al. The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations. Fertil. Steril. 2005, 84:1493-1497.
33. Oppelt P., et al. DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome. Hum. Reprod. 2005, 20:149-157.
34. Oppelt P., et al. Female genital malformations and their associated abnormalities. Fertil. Steril. 2007, 87:335-342.
35. Raga F., Bauset C., Remohi J., Bonilla-Musoles F., Simon C., Pellicer A. Reproductive impact of congenital Mullerian anomalies. Hum. Reprod. 1997, 12:2277-2281.
36. Rall K., et al. A combination of transcriptome and methylation analyses reveals embryologically-relevant candidate genes in MRKH patients. Orphanet J. Rare Dis. 2011, 28(6):32.
37. Ravel C., et al. Mutational analysis of the WNT gene family in women with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil. Steril. 2009, 91:1604-1607.
38. Satokata I., Benson G., Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 1995, 374:460-463.
39. Shokeir M.H. Aplasia of the Mullerian system: evidence for probable sex-limited autosomal dominant inheritance. Birth Defects Orig. Artic. Ser. 1978, 14:147-165.
40. Simpson J.L. Genetics of the female reproductive ducts. Am. J. Med. Genet. 1999, 89:224-239.
41. Small K.M., Potter S.S. Homeotic transformations and limb defects in Hox A11 mutant mice. Genes Dev. 1993, 7:2318-2328.
42. Steinkampf M.P., Dharia S.P., Dickerson R.D. Monozygotic twins discordant for vaginal agenesis and bilateral tibial longitudinal deficiency. Fertil. Steril. 2003, 80:643-645.
43. Strissel P.L., Oppelt P., Cupisti S., Stiegler E., Beckmann M.W., Strick R. Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome). Horm. Metab. Res. 2009, 41:408-413.
44. Sundaram U.T., et al. Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome. Am. J. Med. Genet. A 2007, 143A:2016-2018.
45. Uliana V., et al. Expanding the phenotype of 22q11 deletion syndrome: the MURCS association. Clin. Dysmorphol. 2008, 17:13-17.
46. Warot X., Fromental-Ramain C., Fraulob V., Chambon P., Dolle P. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 1997, 124:4781-4791.
47. Wottgen M., et al. Higher incidence of linked malformations in siblings of Mayer-Rokitansky-Kuster-Hauser-syndrome patients. Hum. Reprod. 2008, 23:1226-1231.
48. Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S., Madden T.L. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012, 13:134.